Acquisitions12 Nov 2025, 07:38 pm
Entero Healthcare Solutions Ltd to Acquire 80% Stake in Bioaide Technologies and 51% Stake in Anand Chemiceutics
AI Summary
Entero Healthcare Solutions Ltd announced that its Board of Directors has approved the acquisition of 80% stake in Bioaide Technologies Private Limited and 51% stake in Anand Chemiceutics Private Limited. The acquisition of Bioaide will cost between INR 31.13 Crore to INR 36 Crore, while the acquisition of Anand Chemiceutics will cost between INR 210 Crore to INR 230 Crore. Both acquisitions are expected to be completed by February 15, 2026.
Key Highlights
- Entero Healthcare Solutions Ltd to acquire 80% stake in Bioaide Technologies Private Limited for a cost ranging between INR 31.13 Crore to INR 36 Crore.
- Entero Healthcare Solutions Ltd to acquire 51% stake in Anand Chemiceutics Private Limited for a cost ranging between INR 210 Crore to INR 230 Crore.
- Both acquisitions are expected to be completed by February 15, 2026.
- Bioaide Technologies Private Limited is engaged in the business of wholesale distribution of medical devices and other healthcare and allied products.
- Anand Chemiceutics Private Limited is engaged in the business of wholesale distribution of medical devices with allied products and turnkey projects in healthcare institutions.